# Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome

> **NCT01071044** · PHASE4 · COMPLETED · sponsor: **Rochester Center for Behavioral Medicine** · enrollment: 26 (actual)

## Conditions studied

- Chronic Fatigue Syndrome
- Cognitive Impairments

## Interventions

- **DRUG:** Lisdexamfetamine Dimesylate
- **DRUG:** Placebo "30, 50 or 70 mg"

## Key facts

- **NCT ID:** NCT01071044
- **Lead sponsor:** Rochester Center for Behavioral Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01071044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01071044, "Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01071044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*